Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Pediatr Blood Cancer. 2014 Sep 9;62(1):65–71. doi: 10.1002/pbc.25133

Fig. 2.

Fig. 2

(A) Leukemia progression plots showing %huCD45+ cells in PB of individual mice engrafted with ALL-7 over time. (B) Kaplan-Meier plot of EFS over time for ALL-7-engrafted mice. (C) Leukemia progression plots showing %hCD45+ cells in PB of individual mice engrafted with T-lineage subtype ALL-8 over time. (D) Kaplan-Meier plot of EFS over time for T-lineage subtype ALL-8-engrafted mice. Dotted lines indicate vehicle-treated control animals while solid lines indicate CPX-351-treated mice.